Cong Xu
Impact in
- Biological Psychiatry top 10%
- Behavioral Neuroscience top 10%
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 2
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Zeruesenay Desta (3 shared papers)Evan T. Ogburn (2 shared papers)Daniel M. Dorsa (1 shared paper)Robert A. Shapiro (1 shared paper)Sylvia K. Plevritis (3 shared papers)Yingying Guo (2 shared papers)Jeanne S. Mandelblatt (2 shared papers)Natasha K. Stout (2 shared papers)
- Journals
- PLoS ONE (3 papers)Drug Metabolism and Disposition (2 papers)Xenobiotica (2 papers)Medical Decision Making (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Cong Xu
42 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 122
- Biological Psychiatry 54
- Behavioral Neuroscience 56
- Pharmacology 223
- Virology 57
- Oncology 304
Countries citing papers authored by Cong Xu
This map shows the geographic impact of Cong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Xu more than expected).
Fields of papers citing papers by Cong Xu
This network shows the impact of papers produced by Cong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Xu. The network helps show where Cong Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 209 | |
| 2 | 2010 | 131 | |
| 3 | 2008 | 109 | |
| 4 | 2012 | 91 | |
| 5 | 2000 | 87 | |
| 6 | 2015 | 62 | |
| 7 | 2018 | 53 | |
| 8 | 2017 | 49 | |
| 9 | 2016 | 37 | |
| 10 | Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer. | 2016 | 30 |
| 11 | 2013 | 25 | |
| 12 | 2013 | 25 | |
| 13 | 2015 | 24 | |
| 14 | 2016 | 23 | |
| 15 | 2014 | 19 | |
| 16 | 2014 | 19 | |
| 17 | 2013 | 17 | |
| 18 | 2014 | 17 | |
| 19 | 2019 | 15 | |
| 20 | 2018 | 15 |
About Cong Xu
Cong Xu is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Immunology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Spine and Intervertebral Disc Pathology (5 papers), Spinal Fractures and Fixation Techniques (5 papers), Breast Cancer Treatment Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer Treatment and Pharmacology (2 papers), Galectins and Cancer Biology (2 papers), Cancer Cells and Metastasis (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Biological Psychiatry (54 citations), Behavioral Neuroscience (56 citations), Pharmacology (223 citations), Virology (57 citations) and Oncology (304 citations). Cong Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zeruesenay Desta, Evan T. Ogburn, Daniel M. Dorsa, Robert A. Shapiro, Sylvia K. Plevritis, Yingying Guo, Jeanne S. Mandelblatt, Natasha K. Stout, Christopher J. Cadham and Allison W. Kurian. Their work appears in journals such as PLoS ONE, Drug Metabolism and Disposition, Xenobiotica, Medical Decision Making and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.